During the past decade, Benu Lekarna conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Benu Lekarna" are "Dermatitis, Atopic" (2 trials), "Rheumatoid Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials), "Dermatitis" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Benu Lekarna" in a lesser frequency.

Most popular intervention types in "Benu Lekarna" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Adalimumab" (1 trials), "Dupilumab" (1 trials) and "Infliximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Benu Lekarna" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Benu Lekarna". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Benu Lekarna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Benu Lekarna, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".